
AIM-LO: Non-HDL Cholesterol: Evolving Evidence Leads to a Novel Strategy
Broadcast Date
Presenter
Eva Lonn, MD, MSc, FRCPC, FACC
Therapeutic Area
Cardiovascular
Dr. Eva Lonn explains why non-HDL cholesterol is now defined as the preferred measurement over LDL-C, particularly for patients with elevated triglycerides, in the 2021 CCS Dyslipidemia guidelines.